AGRX
Agile Therapeutics Inc

17,928
Mkt Cap
$2.74M
Volume
72,919.00
52W High
$6.71
52W Low
$0.20
PE Ratio
-0.04
AGRX Fundamentals
Price
$0.4297
Prev Close
$0.40
Open
$0.40
50D MA
$0.5831
Beta
0.96
Avg. Volume
1.28M
EPS (Annual)
-$9.84
P/B
-0.07
Rev/Employee
$1.03M
EV/EBITDA
-0.28
Loading...
Loading...
Agile Therapeutics, Inc. is a healthcare company, which engages in the development and commercialization of transdermal patches. Its lead product candidate, Twirla, also known as AG200-15, is an investigational low-dose, non-daily prescription contraceptive. The company was founded by Chien Te Yen on December 22, 1997 and is headquartered in Princeton, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
19

Frequently Asked Questions

What is Market Cap of Agile Therapeutics Inc?
What is the 52-week high for Agile Therapeutics Inc?
What is the 52-week low for Agile Therapeutics Inc?
What is Agile Therapeutics Inc stock price today?
What was Agile Therapeutics Inc stock price yesterday?
What is the PE ratio of Agile Therapeutics Inc?
What is the Price-to-Book ratio of Agile Therapeutics Inc?
What is Agile Therapeutics Inc's EBITDA?
What is the 50-day moving average of Agile Therapeutics Inc?
How many employess does Agile Therapeutics Inc has?

Latest AGRX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.